PER 4.29% 6.7¢ percheron therapeutics limited

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-100

  1. 1,031 Posts.
    lightbulb Created with Sketch. 104
    Imperatore... If the product/drug is that good why are people selling out?
    Impatient?.. or can they see further delays in the finalisation of the process?

    Maybe they have a better crystal ball than us?

    Just saying...

    GLTA...

    Zig
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.